MiR-184 expression is regulated by AMPK in pancreatic islets
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
MiR-184 expression is regulated by AMPK in pancreatic islets. / Martinez-Sanchez, Aida; Nguyen-Tu, Marie Sophie; Cebola, Ines; Yavari, Arash; Marchetti, Piero; Piemonti, Lorenzo; De Koning, Eelco; Shapiro, A. M.James; Johnson, Paul; Sakamoto, Kei; Smith, David M.; Leclerc, Isabelle; Ashrafian, Houman; Ferrer, Jorge; Rutter, Guy A.
In: FASEB Journal, Vol. 32, No. 5, 05.2018, p. 2587-2600.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - MiR-184 expression is regulated by AMPK in pancreatic islets
AU - Martinez-Sanchez, Aida
AU - Nguyen-Tu, Marie Sophie
AU - Cebola, Ines
AU - Yavari, Arash
AU - Marchetti, Piero
AU - Piemonti, Lorenzo
AU - De Koning, Eelco
AU - Shapiro, A. M.James
AU - Johnson, Paul
AU - Sakamoto, Kei
AU - Smith, David M.
AU - Leclerc, Isabelle
AU - Ashrafian, Houman
AU - Ferrer, Jorge
AU - Rutter, Guy A.
PY - 2018/5
Y1 - 2018/5
N2 - AMPK is a critical energy sensor and target for widely used antidiabetic drugs. In β cells, elevated glucose concentrations lower AMPK activity, and the ablation of both catalytic subunits [β-cell-specific AMPK double-knockout (βAMPKdKO) mice] impairs insulin secretion in vivo and β-cell identity. MicroRNAs (miRNAs) are small RNAs that silence gene expression that are essential for pancreatic β-cell function and identity and altered in diabetes. Here, we have explored the miRNAs acting downstream of AMPK in mouse and human β cells. We identified 14 down-regulated and 9 up-regulated mi RNAs in β AMPKdKO vs. control islets. Gene ontology analysis of targeted transcripts revealed enrichmentinpathways important for β-cell function and identity. The most down-regulated miRNA wasmiR-184 (miR-184-3p), an important regulator of β-cell function and compensatory expansion that is controlled by glucose and reduced in diabetes. We demonstrate that AMPK is a potent regulator and an important mediator of the negative effects of glucose on miR-184 expression. Additionally, we reveal sexual dimorphism in miR-184 expression in mouse and human islets. Collectively, these data demonstrate that glucose-mediated changes in AMPK activity arecentral for there gulation of miR-184 and other miRNAs in is lets and provide a link between energy status and gene expression in β cells.
AB - AMPK is a critical energy sensor and target for widely used antidiabetic drugs. In β cells, elevated glucose concentrations lower AMPK activity, and the ablation of both catalytic subunits [β-cell-specific AMPK double-knockout (βAMPKdKO) mice] impairs insulin secretion in vivo and β-cell identity. MicroRNAs (miRNAs) are small RNAs that silence gene expression that are essential for pancreatic β-cell function and identity and altered in diabetes. Here, we have explored the miRNAs acting downstream of AMPK in mouse and human β cells. We identified 14 down-regulated and 9 up-regulated mi RNAs in β AMPKdKO vs. control islets. Gene ontology analysis of targeted transcripts revealed enrichmentinpathways important for β-cell function and identity. The most down-regulated miRNA wasmiR-184 (miR-184-3p), an important regulator of β-cell function and compensatory expansion that is controlled by glucose and reduced in diabetes. We demonstrate that AMPK is a potent regulator and an important mediator of the negative effects of glucose on miR-184 expression. Additionally, we reveal sexual dimorphism in miR-184 expression in mouse and human islets. Collectively, these data demonstrate that glucose-mediated changes in AMPK activity arecentral for there gulation of miR-184 and other miRNAs in is lets and provide a link between energy status and gene expression in β cells.
KW - B cell
KW - Diabetes
KW - Glucose
KW - Mirnas
UR - http://www.scopus.com/inward/record.url?scp=85048632168&partnerID=8YFLogxK
U2 - 10.1096/fj.201701100R
DO - 10.1096/fj.201701100R
M3 - Journal article
C2 - 29269398
AN - SCOPUS:85048632168
VL - 32
SP - 2587
EP - 2600
JO - F A S E B Journal
JF - F A S E B Journal
SN - 0892-6638
IS - 5
ER -
ID: 238433779